Liaoning Chengda Biotechnology Co (SHSE:688739) Cyclically Adjusted FCF per Share: ¥0.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688739 Liaoning Chengda Biotechnology Co Ltd SHSE:688739
70 GF Score
Price ¥20.07
GF Value ¥21.99
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Liaoning Chengda Biotechnology Co Cyclically Adjusted FCF per Share?

Liaoning Chengda Biotechnology Co SHSE:688739 -0.94% 70 Cyclically Adjusted FCF per Share is ¥0.92 as of Mar. 2026. GuruFocus rates SHSE:688739 with a GF Score™ of 70/100 and a GF Value™ of ¥21.99 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Liaoning Chengda Biotechnology Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.078. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.92 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Liaoning Chengda Biotechnology Co's average Cyclically Adjusted FCF Growth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-05), Liaoning Chengda Biotechnology Co's current stock price is ¥20.07. Liaoning Chengda Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.92. Liaoning Chengda Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is 21.82.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Liaoning Chengda Biotechnology Co was 29.98. The lowest was 20.79. And the median was 25.90.


Liaoning Chengda Biotechnology Co  (SHSE:688739) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Liaoning Chengda Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=20.07/0.92
=21.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Liaoning Chengda Biotechnology Co was 29.98. The lowest was 20.79. And the median was 25.90.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Liaoning Chengda Biotechnology Co Cyclically Adjusted FCF per Share Related Terms


Liaoning Chengda Biotechnology Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Liaoning Chengda Biotechnology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liaoning Chengda Biotechnology Co Cyclically Adjusted FCF per Share Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.05 0.95

Liaoning Chengda Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.97 0.94 0.95 0.92

SHSE:688739 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:688739
70GF Score
Liaoning Chengda Biotechnology Co Ltd SHSE:688739
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Liaoning Chengda Biotechnology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Liaoning Chengda Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.078/116.3033*116.3033
=-0.078

Current CPI (Mar. 2026) = 116.3033.

Liaoning Chengda Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 100.600 0.000
201606 0.000 101.400 0.000
201612 0.000 102.600 0.000
201703 0.009 103.200 0.010
201706 0.386 103.100 0.435
201709 0.454 104.100 0.507
201712 0.765 104.500 0.851
201803 0.104 105.300 0.115
201806 0.263 104.900 0.292
201809 0.370 106.600 0.404
201812 0.673 106.500 0.735
201903 0.126 107.700 0.136
201906 0.235 107.700 0.254
201909 0.542 109.800 0.574
201912 1.029 111.200 1.076
202003 0.325 112.300 0.337
202006 0.768 110.400 0.809
202009 0.721 111.700 0.751
202012 0.479 111.500 0.500
202103 -0.392 112.662 -0.405
202106 0.071 111.769 0.074
202109 -0.073 112.215 -0.076
202112 0.362 113.108 0.372
202203 -0.349 114.335 -0.355
202206 0.139 114.558 0.141
202209 0.025 115.339 0.025
202212 0.273 115.116 0.276
202303 -0.112 115.116 -0.113
202306 0.098 114.558 0.099
202309 -0.035 115.339 -0.035
202312 0.350 114.781 0.355
202403 -0.151 115.227 -0.152
202406 0.113 114.781 0.114
202409 0.111 115.785 0.111
202412 0.258 114.893 0.261
202503 -0.096 115.116 -0.097
202506 -0.040 114.907 -0.040
202509 -0.060 115.471 -0.060
202512 0.277 115.832 0.278
202603 -0.078 116.303 -0.078

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.92 mean?
Liaoning Chengda Biotechnology Co (SHSE:688739) has a Cyclically Adjusted FCF per Share of ¥0.92 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Liaoning Chengda Biotechnology Co and its competitors.
Is Liaoning Chengda Biotechnology Co's Cyclically Adjusted FCF per Share too high?
Liaoning Chengda Biotechnology Co's current Cyclically Adjusted FCF per Share is ¥0.92. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Liaoning Chengda Biotechnology Co's Cyclically Adjusted FCF per Share of ¥0.92 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Liaoning Chengda Biotechnology Co and its competitors. Liaoning Chengda Biotechnology Co's current Cyclically Adjusted FCF per Share is ¥0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Fairly Valued. The stock's GF Value™ is ¥21.99, compared to a current price of ¥20.07 — trading 8.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.92. Liaoning Chengda Biotechnology Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current Cyclically Adjusted FCF per Share is ¥0.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?

Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued. The current stock price of ¥20.07 is trading 8.7% below its estimated GF Value™ of ¥21.99. GuruFocus considers Liaoning Chengda Biotechnology Co to be Fairly Valued.

Key valuation signals for SHSE:688739:

  • Cyclically Adjusted FCF per Share: ¥0.92
  • GF Value™: ¥21.99 vs. price of ¥20.07 (8.7% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Liaoning Chengda Biotechnology Co Business Description

Address No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
70GF Score

Get the complete analysis for SHSE:688739

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.07
Price
¥21.99
GF Value